Scientific Program - Wilson's disease
Please see below the CONy Scientific Program. Please click on the appropriate section (ordered by ABC) to view the relevant program. Please note that the program and timing is subject to change. To view the program timetable, please click here
|
Alzheimer's disease & other Dementias | Epilepsy | Headache | History of Neurology in Poland |
Multiple Sclerosis | Neuroimmunology | Neuropathy |
Rehabilitation | Stroke | Wilson's disease |
Wislon's disease Section Head: Anna Czlonkowska, Poland |
|
|||
07:00-07:50
|
E-Poster Presentations |
||
08:00-09:50
|
WILSON'S DISEASE (WD): HISTORY, PRESENT, AND FUTURE |
||
Chairs: Adam Przybylkowski, Poland | |||
08:00-08:20 |
|
||
08:20-08:40 |
The new Wilson’s like disease: treatable manganese metabolism disorders causing parkinsonism and dystonia: Antonio Federico, Italy
|
||
08:40-09:00 |
|
||
09:00-09:20 |
|||
09:20-09:30 |
Brain atrophy and neurological impairment in Wilson`s disease: Lukasz Smolinski, Poland
|
||
09:30-09:40 | Transcranial brain parenchyma sonography in Wilson`s disease and healthy controls: quantification and correlations with clinical parameters: Gotthard Tribl, Brazil | ||
09:40-09:50 | Determination of copper poisoning in Wilson’s disease and other metal dysbalances using laser ablation inductively coupled plasma spectrometry: Ralf Weiskirchen, Germany | ||
09:50-10:10 | Coffee Break | ||
10:10-12:10 | WD: PATHOGENESIS, EPIDEMIOLOGY, THERAPY |
||
Chairs: Carl Bjartmar, Sweden & Ermal Kurmaku, Albania | |||
10:10-10:15 | Homage to Anna Czlonkowska: Olivier Bandmann, UK | ||
10:15-10:30 |
|
||
Pathogenesis & Epidemiology
|
|||
10:30-10:50 |
|||
10:50-11:10 |
|
||
Clinical manifestations- great variability
|
|||
11:10-11:30 |
|||
11:30-11:50 |
|
||
11:50-12:10 |
|||
12:10-13:10 | Industry Sponsored Symposium (Not for CME) – Hall A | ||
13:10-13:55 | Lunch Break & Meet the Expert sessions | ||
13:55-15:15 | WD: TREATMENT |
||
Chairpersons: | Malgorzata Wiszniewska, Poland | ||
13:55-14:15 | Current anti-copper therapy: Tomasz Litwin, Poland | ||
14:15-14:35 | We need more options: Karl Heinz Weiss, Germany | ||
14:35-14:55 |
Is liver transplantation a reasonable alternative in patients resistant to chelators? Aurélia Poujois, France
|
||
14:55-15:15 |
Role of botulinum toxin type A in the complex treatment in patients with Wilson disease: Sergey Lobzin, Russia
|
||
15:55-16:15 | Coffee Break | ||